Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

Prevalence of Primary Aldosteronism and Status of Renin-Angiotensin System in Resistant Hypertension:An Observational Study in China

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01459042

Enrollment

2000

Registered

2011-10-25

Start date

2010-01-31

Completion date

Unknown

Last updated

2011-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Resistant to Conventional Therapy

Brief summary

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* patients with resistant hypertension * age 18-65 years

Exclusion criteria

* known cause of hypertension * heart failure * renal dysfunction * Stroke, transient ischaemic attack or myocardial infarction in the past 6 months * cirrhosis * pregnancy * undertreatment of glucocorticoid

Countries

China

Outcome results